Fig. 4From: Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter studyReceiver operating curve of the body mass index for prediction of liver significant fibrosis regression. AUROC of 0.72 (95% CI, 0.593–0.844; p = 0.001)Back to article page